DOJ Delay Raises New Research Questions | TDR Cannabis in 5 cover art

DOJ Delay Raises New Research Questions | TDR Cannabis in 5

DOJ Delay Raises New Research Questions | TDR Cannabis in 5

Listen for free

View show details

About this listen

 What’s actually happening with cannabis research at the federal level — and why does it matter right now?In this episode of TDR Cannabis in Five, the focus turns to a quieter but critical development tied directly to federal cannabis reform. While much of the attention has been on marijuana rescheduling, a key deadline tied to cannabis research quietly passed without action. The U.S. Attorney General missed a congressionally mandated date to issue new rules that would clarify how researchers study Schedule I substances, including cannabis and psychedelics.That delay matters. For decades, federal drug policy has made legitimate cannabis research slow, expensive, and difficult to execute. Congress attempted to address that by directing the Department of Justice to create clearer, more workable registration and research guidelines. The goal was straightforward: reduce administrative friction and allow science to move forward.Instead, researchers are still operating under outdated and inconsistent rules — even as President Trump’s executive order last month directed agencies to complete the process of moving cannabis from Schedule I to Schedule III. The contrast highlights a growing gap between federal intent and federal execution.For scientists, universities, biotech firms, and cannabis operators watching rescheduling closely, this isn’t just procedural noise. Research access influences everything from medical validation and FDA pathways to investment confidence and long-term regulatory credibility.This episode breaks down why the missed deadline matters, how it fits into the broader rescheduling process, and what it signals about the pace of real change inside federal agencies as cannabis reform continues to evolve in 2026.#CannabisResearch #CannabisRescheduling #FederalCannabis #DOJ #PamBondi #DrugPolicy #CannabisScience #TDRCannabisInFive #MarijuanaPolicy #CannabisReformWant to see more Cannabis Reform videos? • Why Trump’s Team Is Highlighting Cannabis ... • Alcohol Rules Change While Cannabis Stays ... • Proposed Hemp Extension Faces Ongoing Unce... • The $4 Billion Problem Facing U.S. Cannabi... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
No reviews yet